Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc. (VYMAB) is a publicly traded company in the Unknown sector. Across all available filings, 1 corporate insiders have executed 1 transactions totaling $211.6K, demonstrating a bearish sentiment with -$211.6K in net insider flow. The most recent transaction on Dec 14, 2020 involved a sale of 4,000 shares valued at $211.6K.
VYMAB Recent Transactions
1 transactionsDate | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 14, 2020 | Gad Thomas | Executive | Sale | 4,000 | $52.89 | $211.6K |
VYMAB Insider Activity Summary
Who Is Buying VYMAB Stock?
No significant insider buying has been recorded for VYMAB in the recent period.
Who Is Selling VYMAB Stock?
No significant insider selling has been recorded for VYMAB in the recent period.
Is Y-mAbs Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for VYMAB is bearish with an Insider Alignment Score of 0/100 and a net flow of -$211.6K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
VYMAB Frequently Asked Questions
Understanding VYMAB Insider Activity
Insider trading at Y-mAbs Therapeutics, Inc. (VYMAB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 1 insiders are actively trading VYMAB stock, having executed 1 transactions in the past 90 days. The most active insider is Thomas Gad (Executive), who has made 1 transactions totaling $211.6K.
Related Tools
Track Y-mAbs Therapeutics, Inc. Insider Activity
Get notified when executives and directors at VYMAB file new Form 4 transactions